FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

734494005: Ruxolitinib phosphate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3507870017 Ruxolitinib phosphate (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3507871018 Ruxolitinib phosphate en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ruxolitinib phosphate Is a Ruxolitinib false Inferred relationship Existential restriction modifier
Ruxolitinib phosphate Has disposition Janus kinase inhibitor true Inferred relationship Existential restriction modifier
Ruxolitinib phosphate Is modification of Ruxolitinib true Inferred relationship Existential restriction modifier
Ruxolitinib phosphate Is a Nitrile true Inferred relationship Existential restriction modifier
Ruxolitinib phosphate Is a Substance with Janus kinase inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Ruxolitinib phosphate Is a Pyrazole derivative true Inferred relationship Existential restriction modifier
Ruxolitinib phosphate Is a Substance with enzyme inhibitor mechanism of action false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely ruxolitinib (as ruxolitinib phosphate) 5 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Ruxolitinib phosphate Inferred relationship Existential restriction modifier 1
Product containing precisely ruxolitinib (as ruxolitinib phosphate) 10 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Ruxolitinib phosphate Inferred relationship Existential restriction modifier 1
Product containing precisely ruxolitinib (as ruxolitinib phosphate) 20 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Ruxolitinib phosphate Inferred relationship Existential restriction modifier 1
Product containing precisely ruxolitinib (as ruxolitinib phosphate) 15 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Ruxolitinib phosphate Inferred relationship Existential restriction modifier 1
Product containing precisely ruxolitinib (as ruxolitinib phosphate) 25 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Ruxolitinib phosphate Inferred relationship Existential restriction modifier 1
Ruxolitinib 5mg tablets Has specific active ingredient True Ruxolitinib phosphate Inferred relationship Existential restriction modifier
Ruxolitinib 10mg tablets Has specific active ingredient True Ruxolitinib phosphate Inferred relationship Existential restriction modifier
Ruxolitinib 10mg tablets Has specific active ingredient False Ruxolitinib phosphate Inferred relationship Existential restriction modifier
Ruxolitinib 5mg tablets Has specific active ingredient False Ruxolitinib phosphate Inferred relationship Existential restriction modifier
Ruxolitinib 15mg tablets Has specific active ingredient True Ruxolitinib phosphate Inferred relationship Existential restriction modifier
Ruxolitinib 20mg tablets Has specific active ingredient True Ruxolitinib phosphate Inferred relationship Existential restriction modifier
Jakavi 5mg tablets (Novartis Pharmaceuticals UK Ltd) Has specific active ingredient True Ruxolitinib phosphate Inferred relationship Existential restriction modifier
Jakavi 15mg tablets (Novartis Pharmaceuticals UK Ltd) Has specific active ingredient True Ruxolitinib phosphate Inferred relationship Existential restriction modifier
Ruxolitinib 15mg tablets 60 tablet Has specific active ingredient True Ruxolitinib phosphate Inferred relationship Existential restriction modifier
Ruxolitinib 5mg tablets 60 tablet Has specific active ingredient True Ruxolitinib phosphate Inferred relationship Existential restriction modifier
Ruxolitinib 20mg tablets 60 tablet Has specific active ingredient True Ruxolitinib phosphate Inferred relationship Existential restriction modifier
Jakavi 20mg tablets (Novartis Pharmaceuticals UK Ltd) 60 tablet Has specific active ingredient True Ruxolitinib phosphate Inferred relationship Existential restriction modifier
Jakavi 20mg tablets (Novartis Pharmaceuticals UK Ltd) Has specific active ingredient True Ruxolitinib phosphate Inferred relationship Existential restriction modifier
Jakavi 5mg tablets (Novartis Pharmaceuticals UK Ltd) 60 tablet Has specific active ingredient True Ruxolitinib phosphate Inferred relationship Existential restriction modifier
Jakavi 15mg tablets (Novartis Pharmaceuticals UK Ltd) 60 tablet Has specific active ingredient True Ruxolitinib phosphate Inferred relationship Existential restriction modifier
Ruxolitinib 5mg tablets 56 tablet Has specific active ingredient True Ruxolitinib phosphate Inferred relationship Existential restriction modifier
Jakavi 5mg tablets (Novartis Pharmaceuticals UK Ltd) 56 tablet 4 x 14 tablets Has specific active ingredient True Ruxolitinib phosphate Inferred relationship Existential restriction modifier
Ruxolitinib 20mg tablets 56 tablet Has specific active ingredient True Ruxolitinib phosphate Inferred relationship Existential restriction modifier
Ruxolitinib 15mg tablets 56 tablet Has specific active ingredient True Ruxolitinib phosphate Inferred relationship Existential restriction modifier
Jakavi 15mg tablets (Novartis Pharmaceuticals UK Ltd) 56 tablet 4 x 14 tablets Has specific active ingredient True Ruxolitinib phosphate Inferred relationship Existential restriction modifier
Jakavi 20mg tablets (Novartis Pharmaceuticals UK Ltd) 56 tablet 4 x 14 tablets Has specific active ingredient True Ruxolitinib phosphate Inferred relationship Existential restriction modifier
Product containing precisely ruxolitinib 5 milligram/1 each conventional release oral tablet Has specific active ingredient False Ruxolitinib phosphate Inferred relationship Existential restriction modifier
Ruxolitinib 10mg tablets 56 tablet Has specific active ingredient True Ruxolitinib phosphate Inferred relationship Existential restriction modifier
Product containing precisely ruxolitinib 10 milligram/1 each conventional release oral tablet Has specific active ingredient False Ruxolitinib phosphate Inferred relationship Existential restriction modifier
Jakavi 10mg tablets (Novartis Pharmaceuticals UK Ltd) 56 tablet 4 x 14 tablets Has specific active ingredient True Ruxolitinib phosphate Inferred relationship Existential restriction modifier
Jakavi 10mg tablets (Novartis Pharmaceuticals UK Ltd) Has specific active ingredient True Ruxolitinib phosphate Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start